Literature DB >> 15201674

Reconstruction of the ocular surface by transplantation of a serum-free derived cultivated conjunctival epithelial equivalent.

Donald T H Tan1, Leonard P K Ang, Roger W Beuerman.   

Abstract

PURPOSE: The purpose of this study was to investigate the use of a serum-free derived cultivated conjunctival epithelial sheet for ocular surface transplantation and reconstruction.
METHODS: Seven subjects with various ocular surface disorders were selected for the procedure: one patient had an extensive conjunctival nevus, three patients had pterygium, two patients had persistent leaking trabeculectomy blebs, and one patient had bilateral superior limbic keratoconjunctivitis. Conjunctival epithelial cells were harvested from the forniceal conjunctiva of patients 2 weeks before the definitive surgery. Cultivation of conjunctival epithelial cells on human amniotic membrane (HAM) was carried out under serum-free conditions. At the time of transplantation, the area of diseased conjunctiva was excised and the cultured conjunctival epithelium-HAM composite was transplanted onto the surgical defect. Patients were followed up with serial slit-lamp examinations, fluorescein staining, and photographic documentation.
RESULTS: A confluent stratified conjunctival epithelial sheet was formed on the HAM within 12 to 14 days. Transplanted grafts remained well-epithelialized after surgery. A successful outcome, defined as resolution of the disease, maintenance of conjunctival epithelialization, maintenance of graft integrity, and absence of significant complications, was obtained in all seven patients. A good functional and cosmetic result was achieved in all eyes. The mean follow-up period was 11.6 months (range, 6-18 months).
CONCLUSIONS: Transplantation of a serum-free derived autologous cultivated conjunctival epithelial sheet on HAM was successfully performed in seven patients with ocular surface disorders. This may provide a novel method for conjunctival replacement in conditions where the normal conjunctiva is damaged or deficient.

Entities:  

Mesh:

Year:  2004        PMID: 15201674     DOI: 10.1097/01.tp.0000127593.65888.a6

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Cultured human ocular surface epithelium on therapeutic contact lenses.

Authors:  Nick Di Girolamo; Jeanie Chui; Denis Wakefield; Minas T Coroneo
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

2.  Treatment of large conjunctival nevus by resection and reconstruction using amniotic membrane.

Authors:  Machiko Tomita; Hiroshi Goto; Ryuji Muramatsu; Masahiko Usui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-11-29       Impact factor: 3.117

3.  Update on amniotic membrane transplantation.

Authors:  Jingbo Liu; Hosam Sheha; Yao Fu; Lingyi Liang; Scheffer Cg Tseng
Journal:  Expert Rev Ophthalmol       Date:  2010-10

4.  Umbilical cord lining stem cells as a novel and promising source for ocular surface regeneration.

Authors:  Hasan Mahmud Reza; Boon-Yee Ng; Federico Luengo Gimeno; Toan Thang Phan; Leonard Pek-Kiang Ang
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

5.  Effect of biopsy location and size on proliferative capacity of ex vivo expanded conjunctival tissue.

Authors:  Jon R Eidet; Ida G Fostad; Marie A Shatos; Tor P Utheim; Øygunn A Utheim; Sten Raeder; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-14       Impact factor: 4.799

6.  Conjunctival reconstruction with progenitor cell-derived autologous epidermal sheets in rhesus monkey.

Authors:  Rong Lu; Xinchun Zhang; Danping Huang; Bing Huang; Nan Gao; Zhichong Wang; Jian Ge
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

7.  Transplantation of Autologous Ex Vivo Expanded Human Conjunctival Epithelial Cells for Treatment of Pterygia: A Prospective Open-label Single Arm Multicentric Clinical Trial.

Authors:  Viraf Sam Vasania; Aarya Hari; Radhika Tandon; Sanjay Shah; Suhas Haldipurkar; Smitesh Shah; Shailendra Sachan; Chandra Viswanathan
Journal:  J Ophthalmic Vis Res       Date:  2014 Oct-Dec

8.  Artificial Polymeric Scaffolds as Extracellular Matrix Substitutes for Autologous Conjunctival Goblet Cell Expansion.

Authors:  Min He; Thomas Storr-Paulsen; Annie L Wang; Chiara E Ghezzi; Siran Wang; Matthew Fullana; Dimitrios Karamichos; Tor P Utheim; Rakibul Islam; May Griffith; M Mirazul Islam; Robin R Hodges; Gary E Wnek; David L Kaplan; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-11-01       Impact factor: 4.799

Review 9.  Potential Role of Induced Pluripotent Stem Cells (IPSCs) for Cell-Based Therapy of the Ocular Surface.

Authors:  Ricardo P Casaroli-Marano; Núria Nieto-Nicolau; Eva M Martínez-Conesa; Michael Edel; Ana B Álvarez-Palomo
Journal:  J Clin Med       Date:  2015-02-12       Impact factor: 4.241

10.  Coculture of autologous limbal and conjunctival epithelial cells to treat severe ocular surface disorders: long-term survival analysis.

Authors:  Sandhya V Subramaniam; Kunjal Sejpal; Anees Fatima; Subhash Gaddipati; Geeta K Vemuganti; Virender S Sangwan
Journal:  Indian J Ophthalmol       Date:  2013-05       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.